Publicaciones en las que colabora con José Luis Labandeira García (11)
2024
-
The role of the brain renin-angiotensin system in Parkinson´s disease
Translational Neurodegeneration, Vol. 13, Núm. 1
2023
-
AT1 receptor autoantibodies mediate effects of metabolic syndrome on dopaminergic vulnerability
Brain, Behavior, and Immunity, Vol. 108, pp. 255-268
-
Extracellular Vesicles and Their Renin–Angiotensin Cargo as a Link between Metabolic Syndrome and Parkinson’s Disease
Antioxidants, Vol. 12, Núm. 12
2022
-
Angiotensin System Autoantibodies Correlate With Routine Prognostic Indicators for COVID-19 Severity
Frontiers in Medicine, Vol. 9
-
Angiotensin type-1 receptor and ACE2 autoantibodies in Parkinson´s disease
npj Parkinson's Disease, Vol. 8, Núm. 1
-
Drugs Modulating Renin-Angiotensin System in COVID-19 Treatment
Biomedicines, Vol. 10, Núm. 2
2021
-
Autoantibodies against ACE2 and angiotensin type-1 receptors increase severity of COVID-19
Journal of Autoimmunity, Vol. 122
-
Experimental data using candesartan and captopril indicate no double-edged sword effect in COVID-19
Clinical Science, Vol. 135, Núm. 3, pp. 465-481
2020
-
Interaction between brain angiotensin and dopaminergic systems and Parkinson’s disease
Genetics, Neurology, Behavior, and Diet in Parkinson’s Disease: The Neuroscience of Parkinson’s Disease, Volume 2 (Elsevier), pp. 463-477
-
Interactions Between the Serotonergic and Other Neurotransmitter Systems in the Basal Ganglia: Role in Parkinson’s Disease and Adverse Effects of L-DOPA
Frontiers in Neuroanatomy, Vol. 14
-
Rho kinase inhibitor fasudil reduces l-DOPA-induced dyskinesia in a rat model of Parkinson's disease
British Journal of Pharmacology, Vol. 177, Núm. 24, pp. 5622-5641